Literature DB >> 31112716

Simultaneous Particle Size Reduction and Homogeneous Mixing to Produce Combinational Powder Formulations for Inhalation by the Single-Step Co-Jet Milling.

Junhong Ling1, Sharad Mangal2, Heejun Park2, Shaoning Wang3, Alex Cavallaro4, Qi Tony Zhou5.   

Abstract

Homogeneous mixing of 2 cohesive jet-milled drug powders is a challenge for pharmaceutical manufacturing on account of their cohesive nature resulting in the formation of strong and random agglomerates. In this study, colistin and ciprofloxacin were co-jet milled to develop combinational antibiotic dry powder formulations for inhalation. The properties of particle size, morphology, content uniformity, and in vitro aerosolization were evaluated. The distribution of 2 drugs in the co-jet milled powders was assessed using time-of-flight-secondary ion mass spectrometry. The co-jet milled powders demonstrated an acceptable content uniformity indicating homogeneity. In general, time-of-flight-secondary ion mass spectrometry images showed relatively homogeneous distributions of ciprofloxacin and colistin in the co-milled formulations. Importantly, the 2 drugs generally had the similar fine particle fraction and deposition behavior in each combinational formulation supporting that the particle mixtures were relatively homogenous and could maximize the antimicrobial synergy. In conclusion, co-jet milling could be a viable technique to produce the combination powders for inhalation.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aerosol performance; dry powder inhaler; jet milling; mixing; uniformity

Year:  2019        PMID: 31112716      PMCID: PMC6708488          DOI: 10.1016/j.xphs.2019.05.011

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  31 in total

1.  Aerosol dispersion of respirable particles in narrow size distributions produced by jet-milling and spray-drying techniques.

Authors:  Margaret D Louey; Michiel Van Oort; Anthony J Hickey
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

2.  Drug/lactose co-micronization by jet milling to improve aerosolization properties of a powder for inhalation.

Authors:  K Giry; J M Péan; L Giraud; S Marsas; H Rolland; P Wüthrich
Journal:  Int J Pharm       Date:  2006-05-12       Impact factor: 5.875

Review 3.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

Review 4.  Spray-dried powders for pulmonary drug delivery.

Authors:  Peter C Seville; Hao-ying Li; Tristan P Learoyd
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

5.  Synergistic antibiotic combination powders of colistin and rifampicin provide high aerosolization efficiency and moisture protection.

Authors:  Qi Tony Zhou; Thomas Gengenbach; John A Denman; Heidi H Yu; Jian Li; Hak Kim Chan
Journal:  AAPS J       Date:  2013-10-16       Impact factor: 4.009

6.  Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation.

Authors:  Qi Tony Zhou; David A V Morton; Heidi H Yu; Jovan Jacob; Jiping Wang; Jian Li; Hak Kim Chan
Journal:  J Pharm Sci       Date:  2013-07-31       Impact factor: 3.534

Review 7.  Inhaled antibiotics to treat lung infection.

Authors:  David Cipolla; Hak-Kim Chan
Journal:  Pharm Pat Anal       Date:  2013-09

8.  Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties.

Authors:  Gabrielle Pilcer; Francis Vanderbist; Karim Amighi
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

9.  Physico-chemical characterisation of surface modified particles for inhalation.

Authors:  Katharina Stank; Hartwig Steckel
Journal:  Int J Pharm       Date:  2013-03-18       Impact factor: 5.875

10.  Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study.

Authors:  Robert Wilson; Tobias Welte; Eva Polverino; Anthony De Soyza; Hugh Greville; Anne O'Donnell; Jeff Alder; Peter Reimnitz; Barbara Hampel
Journal:  Eur Respir J       Date:  2012-09-27       Impact factor: 16.671

View more
  1 in total

1.  State of the Art in Capsule-Based Dry Powder Inhalers: Deagglomeration Techniques and the Consequences for Formulation Aerosolization.

Authors:  Roman Groß; Kai Berkenfeld; Christoph Schulte; Anselm Ebert; Sunita Sule; Ameet Sule; Alf Lamprecht
Journal:  Pharmaceutics       Date:  2022-05-31       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.